Johnson & Johnson Innovation Leads Prazer Therapeutics’s Series B Round
08 Apr 2025
US$ 20.00
Johnson & Johnson Innovation - JJDC Inc (JJDC) has led the 29 bn won (US$20 m) series B financing round of Prazer...
Related Publications
Subscribers’ Weekly for week ending 18 April 2025...
Listen to Australia/New Zealand Funds (Subscribers' Weekly 18 Apr 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.